Showing results (41-50 of 224) with videos related to
Sort By:
Pageof 23
Prostaglandins, Leukotrienes, and Medicine|September 1, 1983
A thromboxane synthetase inhibitor in Raynaud's phenomenonE W Jones, C J HawkeyExpert Opinion on Investigational Drugs|July 5, 2005
Gastrointestinal effects of COX-2 inhibitorsL M Jackson, C J HawkeyClinical Nutrition (Edinburgh, Scotland)|February 1, 1992
Therapeutic approaches to the problem of biliary sludge and gallstone formation during total parenteral nutritionF E Murray, C J HawkeyGut|October 1, 1988
Medical treatment of ulcerative colitis: scoring the advancesC J Hawkey, A B HawthorneEuropean Journal of Gastroenterology & Hepatology|February 12, 1998
Specific mediator-directed therapy for gastrointestinal diseasesW A Stack, C J HawkeyBest Practice & Research. Clinical Gastroenterology|February 28, 2002
Physiology and organ-related pathology of the elderly: stomach ulcersJ I Jones, C J HawkeyDrugs|July 6, 2000
COX-2 selective nonsteroidal anti-Inflammatory drugs: do they really offer any advantages?L M Jackson, C J HawkeyThe American Journal of Medicine|February 13, 2001
Questions regarding future research on aspirin and the gastrointestinal tractB I Hirschowitz, C J HawkeyInternational Journal of Clinical Practice|June 13, 2003
COX-LOX inhibition: current evidence for an emerging new therapyM M Skelly, C J HawkeyBailliere'S Clinical Gastroenterology|June 1, 1994
Treatment of inflammatory bowel disease from now to the millenniumA T Cole, C J HawkeyPageof 23